e-learning
resources
Berlin 2008
Saturday, 04.10.2008
PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interactive case presentation 2 : differentiation between active and latent TB infection
S. Arend (Leiden, Netherlands)
Source:
Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course
Session:
PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course
Session type:
Postgraduate Course
Number:
132
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Arend (Leiden, Netherlands). Interactive case presentation 2 : differentiation between active and latent TB infection. Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation
Tuberculosis in renal transplant recipients on isoniazid prophylaxis
Diagnosis of Latent TB Infection: the role of IGRAs
Related content which might interest you:
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Treatment of latent infection with Mycobacterium tuberculosis: update 2010
Source: Eur Respir J 2011; 37: 690-711
Year: 2011
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015
Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016
Screening migrants for tuberculosis and latent TB infection: the reward will come later
Source: Eur Respir J, 54 (4) 1901719; 10.1183/13993003.01719-2019
Year: 2019
Completion of treatment for latent tuberculosis infection
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
Can we define latent tuberculosis infection?
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003
Introduction of a Latent TB infection (LTBI) screening programme detects cases of active tuberculosis and hepatitis B and C
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Source: Eur Respir J 2010; 36: 135-142
Year: 2010
Diagnosis and treatment of latent tuberculosis infection
Source: Eur Respir Monogr 2018; 82: 381-398
Year: 2018
Persistent M. tuberculosis infection: experimental model of endogenously re-activated TB
Source: Eur Respir J 2002; 20: Suppl. 38, 582s
Year: 2002
Non-cytokine activation immunoprofiling to differentiate treatment status in latent tuberculosis infection
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Latent tuberculosis infection in a drug treatment centre
Source: Eur Respir J 2002; 20: Suppl. 38, 366s
Year: 2002
Latent tuberculosis infection: a new paradigm
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019
Expression of the PDCD1 gene to determine active tuberculosis infection in children and adolescents with latent TB infection
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009
Direct costs of three models for the screening of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 45-50
Year: 2006
Treatment of latent tuberculosis infection: completion rates and adverse effects
Source: Eur Respir J 2003; 22: Suppl. 45, 526s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept